Diatech buys Germany's SensoQuest to move from diagnostic kits into lab instruments
What's the deal? Italian molecular diagnostics company Diatech Pharmacogenetics has acquired Germany-based SensoQuest and launched Labcycler, a compact PCR thermal cycler. The deal, announced in October 2026, hands Diatech control of the Labcycler design and development; terms were not disclosed.
What each side brings: Diatech develops and sells reagents, kits and diagnostic solutions for precision medicine, with a presence in more than 50 countries. SensoQuest originally developed Labcycler, which Diatech now manufactures at its facility in Jesi, Italy.
What's the product? Labcycler performs nucleic acid amplification — a routine step in oncology, forensics, veterinary and environmental testing. Diatech says it is built for up to 600,000 cycles, roughly 20 years of use, and is available now.
What's the endgame? The move pushes Diatech from consumables into instruments, aiming to sell complete molecular-lab solutions through its existing diagnostics reach. "With the acquisition of SensoQuest and the launch of Labcycler, Diatech is taking a strategic step, from reagents and diagnostic kits to complete solutions for the molecular laboratory," said president Fabio Biondi.
Why now? Diatech, which has more than 30 years in molecular diagnostics R&D, had already used and evaluated Labcycler before buying the product outright. Biondi said the quality of "German engineering" convinced the company to take it on.
What could go wrong? The thermal-cycler category is crowded and established. Thermo Fisher introduced its Applied Biosystems PowerFlex cycler in April 2026, and Bio-Rad launched a new PTC Harmony line the same month — leaving Diatech to compete on price, service and performance rather than novelty.
The signal: This is less a breakthrough in PCR than a bid to broaden a reagents business into hardware. Its payoff will hinge on commercial uptake, not the launch alone.
Read more: finanznachrichten.de
Image credit: Generated with Gemini
